Oncology
Commentary
Alleviating chemo-related nausea is a huge unmet need
We control nausea in only half of the patients who receive cisplatin in 2022. That is a huge issue.
Opinion
“I didn’t want to meet you.” Dispelling myths about palliative care
This is the first installment of “Diminutio,” a column by Sarah D’Ambruoso, NP, a palliative care nurse in oncology. Today, she shares stories...
Latest News
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancer
An interim analysis of KEYNOTE-590 found that the combination of pembrolizumab and chemotherapy as first-line treatment, proved superior to...
Latest News
Cancer, infection risk higher in transplant patients than rejection
Patients should be differentiated into two groups: younger, nondiabetic patients who develop graft failure and older often diabetic patients less...
Latest News
Some U.S. women not getting ET for curable breast cancer
Half of breast cancer patients eligible for endocrine therapy are not receiving tamoxifen and aromatase inhibitors.
Latest News
ICIs for NSCLC: Patients with ILD show greater risk
Clinicians need to ask themselves if there are any alternative therapies that might work just as well if not better than ICI therapy for patients...
Latest News
Monotherapy or one-two punch against EGFR-mutant NSCLC?
Clinicians debate whether combining other drugs with osimertinib adds anything but toxicity to the care of patients with EGFR-mutated NSCLC.
News
One in five female oncologists considering leaving academia, survey finds
“There are many indications that women are leaving medicine in disproportionately high numbers,” said Dr. Julie Silver.
Latest News
Can immunotherapy replace surgery for stomach cancer?
The complete pathologic response rate to neoadjuvant nivolumab/ipilimumab was 59%.
Latest News
Could probiotics reduce ‘chemo brain’ in breast cancer patients?
Probiotic treatment given alongside chemotherapy is sufficient to protect against memory disturbances in patients with breast cancer.
